Functional specificity of a protein is linked to its structure. A growing section of bioinformatics deals with the prediction and visualization of protein 3D structures. In homology modelling, a protein sequence with an unknown structure is aligned with sequences of known protein structures. By exploiting structural information from the known configurations, the new structure can be predicted. In this introductory paper, we will present the principles of homology modelling and demonstrate the method used, by determining the structure of the enzyme glutamic decarboxylase (GAD 65). This protein is an autoantigen involved in several human autoimmune diseases. We will illustrate the different steps in structure prediction of GAD 65 by use of two experimentally determined structures of pig kidney DOPA decarboxylase (one structure in complex with the inhibitor carbidopa) as templates. The resulting model of GAD 65 provides detailed information about the active site of the protein and selected epitopes. By analysis of the interactions between the DOPA decarboxylase with the inhibitor carbidopa, the residues of the GAD 65 active site can be identified via the sequence alignment between DOPA and GAD 65. The locations of known epitopes in the molecule are visualized in special representations giving insights into mechanisms of antigenicity. Hydrophobicity analysis gives first hints for the adherence ability of GAD 65 to the cell membrane. Homology modelling is at present one of the most efficient techniques to provide accurate structural models of proteins. It is expected that in few years, for every new determined protein sequence, at least one member with a known structure of the same protein family will be available, which will steadily increase the importance and applicability of homology modelling.
Introduction
Bioinformatics is an interdisciplinary field between information science and molecular biology (1, 2) . A main and important task of bioinformatics in proteomic research is structure prediction and protein modelling (3) . In clinical bioinformatics, proteomic analysis is of relevant value when connected to clinical data (4, 5) . Hence clinical bioinformatics provides a new dimension of molecular insights into preventive, diagnostic and therapeutic medical science. Additionally, genetic profiles will become better accessible and understandable in health and disorders. This might offer the possibility of personalized and individual treatments of patients (6) .
Being able to "see" the 3D structure of a protein and analyze its shape is of crucial importance for understanding protein properties and interaction. The identification of the exact position of the active site offers the possibility of understanding substrate recognition, specificity and inhibition. Since a protein can not be seen optically, no pictures are available (such as, for example, the photographs of cells). Instead a model, resulting from the best fitting of the atoms into the experimental data (determined by x-ray crystallography or nuclear magnetic resonance spectroscopy) must be used (7, 8) . This model of a structure is a threedimensional representation of a protein that reflects the experimental data in a consistent way by providing information about the spatial arrangements of groups of atoms. Once the atomic coordinates of the protein structure have been determined, a table of these coordinates is deposited into the protein database (PDB)-an international repository for 3D structure files (9) . At the moment, the PDB contains more than 44000 stored protein structures. Access to the database is enabled through Internet where PDB structure files, containing the coordinates of every atom in the molecule, can be downloaded and the protein visualized locally. Special software programs (Viewers) convert the atomic coordinates into a view of the molecule and allow manipulation of the molecular model (10) (11) (12) . Additionally physicochemical and biological properties (such as electrostatic potential, hydrophobic/hydrophilic characteristics etc.) can be annotated to the 3D structure and visualized in an appropriate manner (13) (14) (15) .
Because the number of known protein sequences exceeds by far the number of determined structures, the slow and expensive experimental structure determinations are supplemented with theoretical methods (16, 17) . If the structure for a protein of known amino acid sequence has not yet been determined experimentally, it can be predicted by homology modelling (18) (19) (20) . Homology modelling is a form of protein tertiary structure prediction, based on the assumption that proteins that are homologous in sequence are similar in structure. In homology modelling, a protein sequence with an unknown structure (the target) is aligned with one or more protein sequences with known structures (the templates). The necessary condition for successful homology modelling is a detectable similarity between the target sequence and the template sequences (more than 30%) allowing the construction of a correct alignment. The sequence alignment is used to determine the equivalent residues in the target and the template protein. Then the structure of the target protein is constructed by utilizing the information from the template structure. Homology modelling remains, at present, the most efficient technique to provide accurate structural models of proteins. Typical uses of homology modelling are: the design of site-directed mutants to test hypothesis about function, identifying binding sites, improving inhibitors for a given binding site, identifying and predicting antigenic epitopes etc.
In this introductory paper, we will demonstrate the principles and clinical application of homology modelling on the example of the autoantigen glutamic decarboxylase (GAD). This enzyme uses the irreversible α-decarboxylation of L-glutamate as substrate and catalyzes it into γ-aminobutyrate (GABA). GABA and GAD are typically present in several tissues such as the brain, teckis and especially the pancreatic β-cells (21) . In these cells GABA regulates the glucagon secretion. The 65 kDa human isoform of glutamic decarboxylase, GAD 65, is a typical autoantigen in several human autoimmune diseases, such as the insulin-dependent diabetes mellitus (IDDM) and the Stiffman syndrome (22, 23) . In autoimmune diabetes, an attack of inflammatory cells to the endocrine pancreatic β-cells leads to their complete destruction, resulting in the inability to produce insulin for the body's requirements. Because of its antigenic potency GAD 65 plays an important role in experimental immunology (24, 25) . In the case of GAD 65, looking at the protein structure means visualization of specific regions of the protein to discover, which are epitopes, which are binding sites to the substrate etc.
This paper consists of 3 parts: First, we discuss the fundamentals and principles of homology modelling. Additionally we present two widely used programs as concrete and practical realizations of the principles. Second, we demonstrate the different steps of the method by determining the structure of the GAD 65 molecule. Third, we present an analysis of the GAD 65 active site. Finally, the location of exposed amino acid residues in selected epitopes as binding sites for antibodies are visualized and discussed.
Materials and Methods
The protein visualization, sequence alignment and the initiation of the homology modelling shown in this paper, was done with the Swiss-Pdb Viewer (26) . The viewer program runs on a PC with Microsoft Windows. The workspace of the Swiss-Pdb Viewer is divided into several windows (Fig. 1) . The main window is used for manipulation: rotation, zooming, display, several measurements, etc. of protein structures. The control panel provides the selection and manipulation of single residues in the amino acid chain. The alignment window shows the alignment of the sequences and makes it possible to thread a sequence onto a template structure before submitting a homology modelling request to SWISS-MODEL. The 3D protein structure is visualized at the display window.
Two structures are used as templates for homology modelling. The structure files are downloaded from the PDB. One template is the crystal structure of pig kidney DOPA decarboxylase in complex with carbidopa (PDB entry 1JS3) with a resolution of 2.60 angstrom (27) . The second template is the crystal structure of pig kidney DOPA decarboxylase without inhibitor (PDB entry 1JS6) with a resolution of 2.25 angstrom (28).
Principles of homology modelling
Homology modelling is a knowledge-based prediction of protein structures (29, 30) . The method uses parameters extracted from already existing structures to predict a new structure from its sequence. The method of homology modelling is based on the principle that homologue proteins (with similar sequences) have similar structures. This approach is possible because changes in the amino acid sequence usually cause only small structural changes (structures of proteins from the same family are more conserved than their sequences). Therefore homology modelling first involves the finding of already known protein structures in the protein database (PDB) and then building the new sequence onto the homologous template structures (Fig. 2) . It consists of backbone superposition of the atoms, orientation of the side-chains and loop modelling to predict an unknown structure. The steps in homology modelling are:
·The sequence with the unknown structure (the target) is used as a query to find similar sequences with known structures (the templates).
·The sequences are brought into an optimal alignment.
·The backbones of the templates are used to model the protein backbone of the target sequence.
·To fill gaps in the alignment, loop-modelling procedures are used.
Figure 1:
The Swiss-Pdb Viewer emphasis several windows. The main window (top) enables the interactive manipulation of the protein structure in the display window (middle). In the control panel window (right side) individual amino acid residues can be selected for display. The alignment window (bottom) displays the protein sequence. The viewer is used for preparing the homology modelling. After the modelling process, the result of homology modelling is visualized and analyzed. The predicted structure is superimposed on its template structures. Adjustments and improvements of the target template sequence alignment can be made. The mean force potential energy curve (bottom) depicts how well each residue is embedded in its surrounding. The Ramachandran map (bottom, right) shows how well the values of the dihedral angles agree with the values of allowed conformations for protein backbones.
·The side chains are added and their positions are arranged.
·The obtained structure is optimized by energy minimization or knowledge-based optimization.
These steps are found in every method of homology modelling. The output from the homology modelling process is again a structure file in PDB format, containing the atomic coordinates of the calculated structure. Of course the predicted structure in homology modelling is not exactly the same as the template structures (because there are variations in the amino acid sequences). But structural deviations are allowed only in the range of differences found between homologous structures. The crucial point for a successful homology modelling is the quality of the alignment.
The chance of finding a homologous sequence with known structure in the PDB increases because the number of experimentally determined structures is growing rapidly and because the number of different structural folds is very limited due to physical reasons. It is estimated that, in a few years, for every new protein sequence at least one member with known structure of the same family will be available in the database. This shows that the usefulness and success of homology modelling is steadily increasing.
As mentioned above, the first point in homology modelling is finding homologue sequences and building an optimal alignment. Once an optimal alignment exists there are several programs that use the information in the alignment to predict the structure. Two well known programs, which are free for academic research, are MODELLER and SWISS-MODEL. The different programs carry out single steps by proprietary algorithms.
Figure 2:
For a sequence, the structure can be predicted by homology modelling. In homology modelling a protein sequence with an unknown structure (the target) is aligned with one or more protein sequences with known structures (the templates). Homology modelling relies on the rules of spacing between atoms, bond lengths, bond angles etc., from observed values in known protein structures. By considering this structural information from the template structures, the new structure can be predicted.
MODELLER:
Homology modelling with Modeller relies on rules of spacing between atoms, bond lengths, bond angles, dihedral angles etc., from observed values in known protein structures. This information is extracted from the template in the form of spatial restraints. Then the structure of the target is constructed by satisfying all the restraints as well as possible (31, 32) . By applying enough of such restraints, the number of conformations the predicted structure can assume is drastically reduced. These restraints reflect energetically favourable interactions between atoms within the protein. An important feature of the method is that the spatial restraints are obtained empirically from an ensemble of protein structure alignments in a database. Statistical analysis delivers the amount of allowed variations between equivalent pairs in homologous structures expressed as probability density function (quadratic functions, weighted sum of Gaussian functions etc.) The spatial restraints applied to the target, together with energy terms forcing proper stereochemistry, are combined in a function (the objective function) that is optimized during the homology modelling. (Stereochemical restraints are implied by the covalent topology of the molecule including restraints on bond lengths, bond angles, dihedral angles, planarity of rings, chirality of chiral centers and non bonded atomic overlaps). During the first part, the program attempts to optimize the spatial restraints. At the end of the program run, the structure is refined by molecular dynamics with simulated annealing. (A stochastic optimization that involves the simulation of atomic motion in the protein at increasingly lower temperatures, pretending that the objective function corresponds to the energy function). Two files are needed as input to the modeller software: a sequence alignment file and a script file with commands to manipulate the software.
SWISS-MODEL:
The core of the model is build by averaging the backbone atom positions of the template structures, whereas the templates are weighted by the sequence similarity to the target sequence. Starting from conserved residues, the side chains are built by iso-sterically replacement of side chains in template structures (33) (34) (35) (36) . Distortions in the structure, which have been introduced by the rigid modelling, are regulated by energy minimization. The predicted structure is optimized by energy minimization allowing the structure to settle into a lower energy conformation as similar as possible to the modelled conformation. (Energy minimization is a technique that changes the conformation of a molecule in order to decrease its energy as much as possible). SWISS-MODEL is a server for automated homology modelling. With the Swiss-Pdb Viewer, the user can manage complex modelling projects. Suitable templates can be searched, downloaded and manipulated with integrated sequence alignment and structural superposition tools. The target sequence can be mapped onto the template structures and the sequence alignment can be optimized manually. Changes in the modelled target backbone can be immediately seen in the displayed structural superposition. After these manipulations a project file is submitted to the SWISS-MODEL server for structure building. The resulting structure (as PDB coordinate file) is sent back via email with a detailed modelling report. The structure is then visualized with the Swiss-Pdb Viewer.
Prediction of the GAD 65 structure
In this chapter, we will describe the steps in the procedure of homology modelling in more detail. To illustrate the principles, we have done the homology modelling for the GAD 65 sequence with SWISS-MODEL by using two structures of pig kidney DOPA decarboxylase (DDC) as templates. The GAD 65 molecule is build up of two identical peptide chains (homo dimer). One peptide sequence of GAD 65 contains 585 residues and the molecule is build up of 3920 atoms per chain (37) .
First the GAD 65 sequence is used as a query to search the PDB for homologous sequences of known structures. For this purpose the program BLAST (Basic Local Alignment Search Tool) was used. The query sequence is entered via a simple web form. This program performs pairwise comparisons of sequences (38, 39) . For the evaluation of the amino acid exchange the substitution matrix BLOSUM62 was used (40) . The values in the substitution matrix reflect naturally occurring mutations in proteins and are derived from the probability of amino acid pairs observed in a sequence alignment inside protein families. As a result, the sequence of DOPA decarboxylase from pig kidney was found as homologue. The alignment shows an Evalue (expection-value) of 3e-26. The E-value reflects the likelihood that a given sequence alignment is just random (occurred by chance). Alignments with low Evalues are very significant, that means there is a high probability that the sequences are homologous.
The structural information of the templates is available from the PDB and the appropriate structure files were downloaded. Two structures of DOPA decar-boxylase were selected as templates for the homology modelling: one structure with the inhibitor carbidopa and one structure without inhibitor. The crystal structure of DOPA decarboxylase is a homo-dimer (Fig. 3) . With the Swiss-Pdb viewer software an alignment of the templates and the target was produced (Fig. 4) . Most of the alignment is done automatically, but by manual aligning as many residues as possible in regions with weaker homology the length of gaps can be minimized. Parts of the protein sequence can be manually threaded by use of a mean force potential. The mean force potential energy is displayed for each residue (Fig. 1) Figure 3 : The crystal structure of pig kidney DOPA decarboxylase (DDC) is used as a template. The structure consists of two identical amino acid chains (Homo Dimer). In the figure the protein is shown in complex with the inhibitor Carbidopa. The chains (dark and bright) are represented as ribbons, whereas the inhibitors are represented as "ball and stick". keys in the alignment window) in the alignment the curve shows how the situation for the residues changes. The curve either decreases or increases locally. Areas of weakest homology are usually loops, which can be improved by manual interventions. This alignment was then used as input for the homology modelling and the structure is built up by threading the GAD 65 sequence into the template structures (Fig. 5) .
The resulting structure is optimized by performing an energy minimization of the molecular force field (41) . The force field, describing atomic interactions in the molecule such as bond energy, van-der-Waals energy, Coulomb energy etc., is based on empirical functions with analytical forms. Force fields are energy terms that contain mainly different potentials describing the interactions between pairs of particles. Chemically unreasonable configurations occur, for example, from energetically unfavourable covalent bonds and steric hindrance of side chains. The energy of covalent bonds depends from bond length, bond angle and the dihedral angles (Fig. 6) . Due to the stretching of bond lengths and the distortions of bond and dihedral angles, energetically unfavourable situations may occur. Steric hindrance results from the overlapping of the residues' van-der-Waals radii, which leads to strong repulsive forces. The van-derWaals radius of an atom is the radius of the sphere around the atom centre, inside which another atoms spherical boundary can't pass because the repulsive force between the electrons of both atoms begins to increase sharply. Energy minimization of the molecular force field establishes physically realistic configurations by avoiding energetically unfavourable configurations.
The resulting structure of GAD 65 is then visualized and analyzed with the integrated tools of the Swiss-PDB viewer. 
Figure 5:
The target sequence is "wrapped" around the template structure. The structure of the target is constructed by satisfying all the restraints, taken from the template structures, as well as possible. The structure of the target sequence is visualized as a "ball-and-stick" representation. The template structure is visualized as a backbone ribbon.
Results
The structure shows a seven stranded β-sheet surrounded by eight α-helices and four-stranded β-sheet surrounded by three α-helices. The N-terminal and the C-terminal contains α-helices (Fig. 7) .
First the resulting GAD 65 structure was compared with the one in previous literature. The structure of GAD 65 has recently been predicted with the MOD-ELLER software and by the use of pig kidney DOPA decarboxylase and Escherischia coli glutamate decarboxylase isoform B (GadB) as templates (42) . To compare the structures obtained by two different methods, they are superposed and the differences of the Cα-atom positions of the backbones in the two structures are measured. The differences between two protein structures are expressed by the root mean squared deviation (RMS) of the respective atomic positions in the two structures. The structures of GAD 65 predicted by two homology modelling methods (MOD-ELLER and SWISS-MODEL) show a good correlation in basic parts, especially in the region where the binding sites are located (RMS=0.88 angstroms).
Structural information on GAD 65 enables an understanding of the biochemical features of the enzyme and rationalizes findings from epitope mappings. The model of GAD 65 provides detailed information about the active site of the protein. By analyzing the active site, the residues most likely involved in catalysis and substrate recognition, paving the way for rational mutagenesis studies of the GAD 65 reaction mechanism, specificity and inhibition are identified.
Analysis of the active site
The active site of GAD 65 is very similar to that of the DOPA decarboxylase molecule and several active site residues are highly conserved. The analysis was Figure 6 : The peptide backbone is coloured in white, whereas the side chains are gray. Realistic values for bond length, bond angle and dihedral angles are determined from known structures. Steric interactions arise when the van-der-Waals spheres of two non bonded atoms are approaching and overlapping each other. The radius of the van-der-Waals sphere is defined as the distance at which the repulsive force begins to increase sharply. Through energy minimization configurations with physically realistic values of bond lengths, bond angles and dehidral angles are realised.
done by selecting the position of the inhibitor in the protein structure. The active site of DOPA decarboxylase was then determined by identifying all the residues located at a range of 3.6 angstroms (typical range of hydrogen bonds) from the inhibitor carbidoba (Fig.8) . The alignment of the DOPA decarboxylase sequence with the sequence of GAD 65 shows that the residues involved in the active site are conserved (Fig.  3) . These are tyrosin (DOPA: T246, GAD65: T339), asparagin acid (DOPA: D271, GAD65: D364), alanin (DOPA: A273, GAD65: A366), asparagin (DOPA: N300, GAD65: N393), histidin (DOPA: H302, GAD65: H395), lysine (DOPA: K303, GAD65: K396). The corresponding residues of the GAD 65 molecule are determined from the alignment and the resulting active site of GAD 65 is shown in Fig. 9 . The structural superposition of the DOPA structure and the GAD65 structure shows a perfect matching of the corresponding residues of the active sites in both molecules. Structural deviations between the geometry of both active sites are small.
Visualization and analysis of epitopes
The epitopes of GAD 65 has been identified by epitope mapping studies (43, 44) . The location of selected epitopes are mapped onto the structure and highlighted. The following epitopes of GAD 65 has been selected for visualization (on chain B): M5 (E517, E520, Pteridines/Vol. 18/No. 3
Figure 7:
The structure of GAD 65 predicted with homology modelling. Only one chain of the homo-dimer is shown. N-terminal and C-terminal are indicated. The β-sheets and α-helices are visualized. The seven stranded β-sheet is surrounded by eight α-helices and the four-stranded β-sheet surrounded by three α-helices.
E521, S524, S527), DPC (P231, G232, G233, S234) and M4 (K358). The epitopes show exposed amino acid residues (Fig. 10) . The residues of the epitopes are represented by the van-der-Waals radii of their atoms. The van-der-Waals radii approximate the molecular surface, which is useful for studying protein-protein interactions by visualizing the shape of dogging sites (Fig. 10) . The molecular surface can be considered as the boundary of the molecule volume within no other molecule can enter. The analysis and visualization of epitopes in the GAD 65 molecule provide detailed structural information and is fundamental for the understanding of the mechanisms of antigenicity at a molecular level. The electrostatic field of the protein has been calculated and the partial atomic charges in the epitopes residues visualized (Fig. 11) . The partial charges of the atoms are helpfully for the interpretation of interactions responsible for antigenicity.
Discussion
In this presentation, we show the basic principals of homology modelling and draw a crystal structure of the GAD 65 antigen. The success and applicability of homology modelling is steadily increasing because of the growing number and availability of experimentally determined protein structures. In future, this will augment the chance, that for every protein family at least one member with a known structure will be available. There exists a great variety of different proteins but the number of possible structural folds is limited due to physical reasons, which is a great argument for the theoretical basis and practical applicability of homology modelling.
Molecular medicine means the understanding of metabolism and diseases at a molecular level. From this point of view, new possibilities for the treatment of Figure 8 : Crystal structure of DOPA decarboxylase in complex with the inhibitor carbidoba (chain A from the homo-dimer is shown). The residues of the active site (represented as "balls-and-sticks") bind the inhibitor (white) via hydrogen bonds. The residues of the active site of DOPA are found by detecting residues in a radius of possible H-bonds (3.6 angstrom) around the inhibitor molecule. The H-bonds are represented as doted lines. diseases are expected. With homology modelling, accurate structural molecular models of proteins are provided. These models offer the possibility to understand substrate specificity by analysing and visualizing of the active sites, understanding antigenicity by determining the shape of epitopes etc. This may be helpfully for rational diagnosis and the development of new therapies, founded on evidence based medicine. In the case of GAD 65, the molecular visualization enables a better understanding of the antigenic determinants. Additionally, the induction to an immune response could be understood and measured.
Hitherto, the GAD antigen has been considered to be strictly intracellular. This is a misconception for the understanding in immunology since an intracellular antigen would not have access to the immune system. For this reason, it is expected that the GAD molecule can be reversibly anchored to cell membranes. Hydrophobic regions in the protein can be evaluated from the constituent residues (45) . Additionally characterisation of hydrophobicity can be visualised by the mapping of hydrophobic properties onto the protein structure and representation with colour encoding (Fig.  12 ). This analysis may give first hints for understanding the interaction of the GAD antigen with the cell membrane, the penetration and the inclination of the molecule for adherence to the cell membrane.
The importance of these findings is enormous since we can visualise the various determinants to be studied for the building up of a passive immune therapy. Passive immune therapy would be the key to switch off an ongoing auto aggression and hence eradicating autoimmunity.
Conclusion
In conclusion homology modelling is a tool for genPteridines/Vol. 18/No. 3 Figure 9 : Active site of GAD65. Starting from the residues of the active site of the DOPA molecule (Fig. 8) , the corresponding residues of the GAD65 molecule are determined from the alignment (Fig. 4) . The residues are labelled by name and number and represented as "balls-and-sticks". erating accurate structural models of proteins. This enables a better understanding of the functional behaviour of molecules, like GAD 65, and the presentation of antigenic determinants from these structures. The molecular structure of the GAD 65 antigen also helps us to understand how an ongoing immune response can be interrupted by the passive administration of responder molecules.
